Page last updated: 2024-08-17

medroxyprogesterone acetate and Trichomonas Vaginitis

medroxyprogesterone acetate has been researched along with Trichomonas Vaginitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, S; Brill, I; Chomba, E; Haddad, LB; Kilembe, W; Sharkey, T; Tichacek, A; Tote, K; Vwailika, B; Wall, KM1
Baeten, JM; Hassan, WM; Jaoko, W; Kiarie, J; Lavreys, L; Mandaliya, K; McClelland, RS; Ndinya-Achola, J; Sangare, L1
Baeten, JM; Bwayo, JJ; Chohan, B; Kreiss, JK; Lavreys, L; Mandaliya, K; Martin, HL; Ndinya-Achola, JO; Nyange, PM; Richardson, BA1

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Trichomonas Vaginitis

ArticleYear
Hormonal Contraception and Vaginal Infections Among Couples Who Are Human Immunodeficiency Virus Serodiscordant in Lusaka, Zambia.
    Obstetrics and gynecology, 2019, Volume: 134, Issue:3

    Topics: Adult; Candidiasis, Vulvovaginal; Contraceptives, Oral, Hormonal; Female; HIV Seronegativity; HIV Seropositivity; Hormonal Contraception; Humans; Male; Medroxyprogesterone Acetate; Sexual Partners; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial; Zambia

2019
Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.
    The Journal of infectious diseases, 2007, Mar-01, Volume: 195, Issue:5

    Topics: Adult; Alcohol Drinking; Delayed-Action Preparations; Education; Female; HIV Infections; HIV-1; Humans; Kenya; Levonorgestrel; Medroxyprogesterone Acetate; Risk Factors; Sex Work; Time Factors; Trichomonas Vaginitis

2007
Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.
    American journal of obstetrics and gynecology, 2001, Volume: 185, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Candidiasis, Vulvovaginal; Chlamydia Infections; Cohort Studies; Condoms; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Gonorrhea; Humans; Kenya; Medroxyprogesterone Acetate; Middle Aged; Pelvic Inflammatory Disease; Prospective Studies; Risk Factors; Sex Work; Sexual Behavior; Sexually Transmitted Diseases; Trichomonas Vaginitis; Vaginosis, Bacterial

2001